Page 8 - Agvhd News Today

LVHD and LVHI -- two of the more venerable names among high-dividend low-volatility exchange traded funds -- are changing names.

Despite rising interest, plenty of high-dividend equities are outperforming the broader market this year. Some are even generating positive returns.

Jakavi treats a potentially life-threatening condition which often effects transplant patients - News - PharmaTimes

There are many activities and events in the Greater New Milford area over the coming...

The Naugatuck Valley Health District is preparing its latest strategic plan, and the...

There are many news and events taking place in the greater New Milford area.

Spotlight Featured Researcher Rainer Storb is one of the pioneers who established donor blood stem cell transplantation as a cure for diseases like leukemia and aplastic anemia.

The Food and Drug Administration on December 15 approved the first-ever drug to be used for the prevention of acute graft versus host disease (aGVHD) in adult and pediatric patients, opening the door for safer bone marrow and blood stem cell transplants in patients who do not have a perfectly matched graft donor.

Thành viên HĐQT kiêm Phó Tổng Giám đốc Nguyễn Thị Thanh Huyền đăng ký mua 9,57 triệu cổ phiếu DIG.

Cổ đông lớn Kinh doanh Địa ốc Him Lam đã bán 3,35 triệu cổ phiếu DIG.